Results

Total Results: 6,952 records

Showing results for "weeks".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
    April 18, 2013 - The KQs were then posted for public comment for 4 weeks from April 12, 2012 to May 10, 2012, and the … Reviewer 3 Children Report, Executive summary: On average, the trials lasted 20 weeks and therefore … above 85% vs. 14% children with drug vs. placebo respectively reported no migraine attacks at 26 weeks
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
    March 01, 2013 - increase from baseline calculated by study investigators) that was comparable to acupuncture at 32 weeks … acupuncture when compared with no intervention or alternate placement of acupuncture needles.61,63 By 32 weeks … the trial of electroacupuncture for PCOS,61 women who received 14 acupuncture treatments over 16 weeks
  3. effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
    January 01, 2017 - fetal demise; other PCFs- Differences between in reasons for induction, gestational age (37 to 41 weeks … vs >41 weeks); Table 4; ORs compare IP vs. … IP had GA ≥42 weeks at induction; (15.7% vs. 33.8%); Methods indicate multivariate regression done but
  4. www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dxsafety-particpant-workbook.pdf
    February 04, 2022 - “You should complete the test within 2 weeks and come back to see me so we can talk about the results … “You should complete the test within two weeks and come back to see me so we can talk about the results … � Follow-up � Tests � Yes � Days � No � Weeks � Longer � No � Medicine refill � Treatments �
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/oaVhMNVAnx3b5-UUunZkjr
    December 17, 2018 - Follow-up: Less than 3 months (12 weeks) of follow-up after baseline (does not apply to harms). … Duration ranged from 1 day to more than 3 years, with a me- dian of 6 weeks (interquartile range, 1 day … to 26 weeks).
  6. www.uspreventiveservicestaskforce.org/home/getfilebytoken/oZSntFpszryu7mAnjdhkrw
    September 05, 2023 - participants in the wait-list control group only withdrew from the study because of risk of suicide by 17 weeks … suicidal ideation (5/139 [3.6%] vs 1/76 [1.3%]), and suicidal attempts (no event in either group) by 12 weeks … Three pharmacotherapy studies reported on suicide-related harms at the end of treatment at 8 to 12 weeks
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
    June 11, 2019 - diphosphate levels in dried blood spot sampling consistent with �4 doses/wk) of 66% to 90% over 4 to 48 weeks … reported lower rates of adher- ence to PrEP (based on blood spot sampling) of approximately 50% at 12 weeks … , decreasing to 34% and 22% at 48 weeks.16,54 Two studies in US men who have sex with men found that
  8. www.ahrq.gov/sites/default/files/wysiwyg/mcc/pccp4p/measures-rapid-scan-report.pdf
    April 10, 2025 - The second measure is having a follow-up on that goal within two weeks to six months. … individuals 18 years and older with a complex care need who received follow-up on their PCO goal within 2 weeks … individuals 18 years of age or older with a complex care need who achieved their PCO goal within two weeks
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-noninvasive-nonpharma.pdf
    April 01, 2022 - General Inclusion Criteria • Adults with the following chronic pain (defined as pain lasting 12 weeks … Chronic headache is defined as 15 or more days each month for at least 12 weeks or history of headache … The effect of two weeks of spinal manipulative therapy and home stretching exercises on pain and disability
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol.pdf
    October 15, 2024 - through 5 years of the final menstrual period [10 years for Black and Hispanic women]) At least 12 weeks … duration of treatment Later onset of treatment Less than 12 weeks duration of treatment Sample … evidence and data will be solicited from the public on the Effective Health Care (EHC) website for 4 weeks
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
    October 15, 2024 - through 5 years of the final menstrual period [10 years for Black and Hispanic women]) At least 12 weeks … duration of treatment Later onset of treatment Less than 12 weeks duration of treatment Sample … evidence and data will be solicited from the public on the Effective Health Care (EHC) website for 4 weeks
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
    July 01, 2014 - with treatment regimen • Parameters at birth and up to 12 months of age: preterm birth (e.g., < 32 weeks … , < 37 weeks); appropriate growth (height, weight, and head circumference); gestational age (e.g., … suggested that SSRIs have no statistically significant effect on rates of preterm birth (defined as <37 weeks
  13. digital.ahrq.gov/sites/default/files/docs/lessons-covid19-slides-07012021.pdf
    July 01, 2021 - AHRQ National Web Conference - Slide AHRQ National Web Conference on Opportunities for Digital Healthcare: Lessons Learned From the COVID-19 Pandemic Moderated by: Arlene Bierman, MD, MS Agency for Healthcare Research and Quality Presented by: Jerry Osheroff, MD Alex Krist, MD, MPH Robert S. Rudin, PhD July 1,…
  14. psnet.ahrq.gov/perspective/conversation-jack-needleman-phd
    September 01, 2012 - In Conversation With… Jack Needleman, PhD September 1, 2012  Also Read an Essay Citation Text: In Conversation With… Jack Needleman, PhD. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2012…
  15. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/fallsprev/ontimefallpxoverviewmaterialspacket.pdf
    June 02, 2025 - Abt Single-Sided Body Template On-Time Falls Prevention: Overview Materials Packet Samples of four types of reports are provided here: • On-Time Falls High-Risk Report. • Quarterly Summary of Falls Risk Factors by Unit or Facility. • Monthly Contextual Factors Report. • Postfall Assessment Summary Report. …
  16. digital.ahrq.gov/sites/default/files/docs/publication/uc1hs016151-mathews-final-report-2008.pdf
    January 01, 2008 - Transforming Healthcare Quality through Information Technology (THQIT) 1 Grant Final Report Grant ID: 5UC1HS016151 Transforming Healthcare Quality through Information Technology (THQIT) Inclusive Dates: 09/30/05 - 09/29/08 Principal Investigator: Craig A. Mathews Team Member Organizations:…
  17. psnet.ahrq.gov/web-mm/intubation-mishap
    April 26, 2023 - SPOTLIGHT CASE Intubation Mishap Citation Text: Weinger MB, Blike G. Intubation Mishap. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2003. Copy Citation Format: Google Scholar BibTeX EndNote X3 XML EndNote …
  18. psnet.ahrq.gov/web-mm/diagnosing-hiv-it-doesnt-take-brain-surgeon
    January 01, 2018 - SPOTLIGHT CASE Diagnosing HIV-It Doesn't Take a Brain Surgeon Citation Text: Chou R. Diagnosing HIV-It Doesn't Take a Brain Surgeon. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2008. Copy Citation Format: …
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
    September 02, 2016 - Transparency of Reporting Requirements: Management of Infertility Source: www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 Evidence-based Practice Center Methodology Repor t Protocol Project Title: Transparency of Repor ting Requirements Repor t Topic: Management of Infer tility …
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/c-7ARQE9RuXKjjpeLABkaH
    March 01, 2007 - Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement U.S. Preventive Services Task Force* This statement sum…